UCHD, Protecting Your Health.

 

Epidural Steroid Injection Health Alert

Ohio Contacting Patients Who Received Epidural Steroid Injection
The Ohio Department of Health (ODH) released the names of healthcare facilities in the state that received a recalled epidural steroid injection. Local health departments and facilities have been working diligently to contact any patient who received the treatment which is most frequently used to treat back pain.
 
Facilities which received the recalled product have been contacted by their local health department. At this time, FDA has notified ODH that the following clinics received the above recalled medication:
 
• BKC Pain Specialists, 1065 Delaware Ave., Marion, OH 43302
• Cincinnati Pain Management, 8261 Cornell Rd., Cincinnati, OH 45249
• Marion Pain Clinic, 1199 Delaware Ave., Marion, OH 43302
• Ortho-Spine Rehab Center, 7211 Sawmill Rd. Suite 101, Dublin, OH 43016
 
“It’s very important that we reach out to those who had the treatment because symptoms are subtle and can be overlooked,” said Dr. Ted Wymyslo, Director of ODH. “As we look harder, it is possible that we will uncover cases. We want to get these patients connected with treatment to prevent more serious consequences.”
 
Patients who received a steroid injection, and are experiencing symptoms such as a new or worsening headache, fever, neck stiffness, or pain at the injection site, should contact their healthcare provider to determine if they have received one of the recalled products and to receive further evaluation.
 
The Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) are coordinating a multi-state investigation of meningitis among patients who had received epidural steroid injection. At least five deaths have been reported. Fungal meningitis, which is not transmitted from person to person, is suspected to be the cause of the outbreak. A potentially contaminated product may be the source of the infection, though investigation into the exact source is still ongoing.
 
Interim data show that all infected patients received injection with preservative-free methylprednisolone acetate (80mg/ml) prepared by the New England Compounding Center, located in Framingham, MA. The lots of medication that were used on infected patients have been recalled. The lots are:
• Methylprednisolone Acetate (PF) 80 mg/ml Injection, Lot #05212012@68, BUD 11/17/2012
• Methylprednisolone Acetate (PF) 80 mg/ml Injection, Lot #06292012@26, BUD 12/26/2012
• Methylprednisolone Acetate (PF) 80 mg/ml Injection, Lot #08102012@51, BUD 2/6/2013
Clinicians are also requested to report any suspected adverse events following use of these products to FDA's MedWatch program at 1-800-332-1088 www.fda.gov/medwatch or contact their local health department.
 
 
*Information taken from October 5, 2012 press release from the Ohio Department of Health.
Click here for the latest guidance for healthcare providers and more infromation on this recall and outbreak from the Centers for Disease Control.

Related items